HEADER APOPTOSIS 04-FEB-15 5AGX TITLE BCL-2 ALPHA BETA-1 LINEAR COMPLEX COMPND MOL_ID: 1; COMPND 2 MOLECULE: APOPTOSIS REGULATOR BCL-2, BCL-2-LIKE PROTEIN 1, APOPTOSIS COMPND 3 REGULATOR BCL-2; COMPND 4 CHAIN: A; COMPND 5 FRAGMENT: RESIDUES 1-34,29-44,92-207; COMPND 6 SYNONYM: BCL2-L-1, APOPTOSIS REGULATOR BCL-X; COMPND 7 ENGINEERED: YES; COMPND 8 OTHER_DETAILS: CONTAINS RESIDUES 1-34,92-207 OF BCL-2 AND THE COMPND 9 UNSTRUCTURED LOOP BETWEEN RESIDUES 35-91 REPLACED IS WITH RESIDUES COMPND 10 35-50 OF BCL-XL; COMPND 11 MOL_ID: 2; COMPND 12 MOLECULE: APOPTOSIS REGULATOR BCL-2, BCL-2-LIKE PROTEIN 1, APOPTOSIS COMPND 13 REGULATOR BCL-2; COMPND 14 CHAIN: B; COMPND 15 FRAGMENT: RESIDUES 1-34,29-44,92-207; COMPND 16 SYNONYM: BCL2-L-1, APOPTOSIS REGULATOR BCL-X; COMPND 17 ENGINEERED: YES; COMPND 18 OTHER_DETAILS: CONTAINS RESIDUES 1-34,92-207 OF BCL-2 AND THE COMPND 19 UNSTRUCTURED LOOP BETWEEN RESIDUES 35-91 REPLACED IS WITH RESIDUES COMPND 20 35-50 OF BCL-XL; COMPND 21 MOL_ID: 3; COMPND 22 MOLECULE: BCL-2-LIKE PROTEIN 11; COMPND 23 CHAIN: C, D; COMPND 24 FRAGMENT: BIM BH3, RESIDUES 146-166; COMPND 25 SYNONYM: BCL2-L-11, BCL2-INTERACTING MEDIATOR OF CELL DEATH; COMPND 26 ENGINEERED: YES; COMPND 27 OTHER_DETAILS: BIM BH3 WITH CYCLIC BETA AMINO ACIDS AT RESIDUES 2,6, COMPND 28 16 AND PENTENY AMINO ACIDS AT RESIDUES 9,13 SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PGEX-6P-3; SOURCE 10 MOL_ID: 2; SOURCE 11 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 12 ORGANISM_COMMON: HUMAN; SOURCE 13 ORGANISM_TAXID: 9606; SOURCE 14 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 15 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 16 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 17 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 18 EXPRESSION_SYSTEM_PLASMID: PGEX-6P-3; SOURCE 19 MOL_ID: 3; SOURCE 20 SYNTHETIC: YES; SOURCE 21 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 22 ORGANISM_COMMON: HUMAN; SOURCE 23 ORGANISM_TAXID: 9606 KEYWDS FOLDAMER, BIM, APOPTOSIS EXPDTA X-RAY DIFFRACTION AUTHOR B.J.SMITH,E.F LEE,J.W.CHECCO,S.H.GELLMAN,W.D.FAIRLIE REVDAT 4 01-MAY-24 5AGX 1 REMARK REVDAT 3 15-NOV-23 5AGX 1 LINK ATOM REVDAT 2 23-SEP-15 5AGX 1 JRNL REVDAT 1 09-SEP-15 5AGX 0 JRNL AUTH J.W.CHECCO,E.F.LEE,M.EVANGELISTA,N.SLEEBS,K.RODGERS, JRNL AUTH 2 A.PETTIKIRIARACHCHI,N.KERSHAW,G.A.EDDINGER,D.G.BELAIR, JRNL AUTH 3 J.L.WILSON,C.H.ELLER,R.T.RAINES,W.L.MURPHY,B.J.SMITH, JRNL AUTH 4 S.H.GELLMAN,W.D.FAIRLIE JRNL TITL ALPHA BETA PEPTIDE FOLDAMERS TARGETING INTRACELLULAR JRNL TITL 2 PROTEIN-PROTEIN INTERACTIONS WITH ACTIVITY ON LIVING CELLS JRNL REF J.AM.CHEM.SOC. V. 137 11365 2015 JRNL REFN ISSN 0002-7863 JRNL PMID 26317395 JRNL DOI 10.1021/JACS.5B05896 REMARK 2 REMARK 2 RESOLUTION. 2.24 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE: 1.9_1692) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.24 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 40.01 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.360 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 20250 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.191 REMARK 3 R VALUE (WORKING SET) : 0.188 REMARK 3 FREE R VALUE : 0.245 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1013 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 40.0151 - 4.2840 1.00 2931 155 0.1647 0.2137 REMARK 3 2 4.2840 - 3.4009 1.00 2767 145 0.1728 0.2256 REMARK 3 3 3.4009 - 2.9711 1.00 2743 145 0.2097 0.2662 REMARK 3 4 2.9711 - 2.6996 1.00 2723 143 0.2022 0.2343 REMARK 3 5 2.6996 - 2.5061 1.00 2705 142 0.2017 0.3084 REMARK 3 6 2.5061 - 2.3584 1.00 2703 143 0.2147 0.2613 REMARK 3 7 2.3584 - 2.2403 0.99 2665 140 0.2630 0.3823 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.290 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 25.410 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.007 2773 REMARK 3 ANGLE : 1.105 3773 REMARK 3 CHIRALITY : 0.042 391 REMARK 3 PLANARITY : 0.005 483 REMARK 3 DIHEDRAL : 23.231 1008 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: ALL REMARK 3 ORIGIN FOR THE GROUP (A): 96.6440 79.1155 8.9341 REMARK 3 T TENSOR REMARK 3 T11: 0.1879 T22: 0.2929 REMARK 3 T33: 0.2442 T12: 0.0486 REMARK 3 T13: -0.0111 T23: -0.0035 REMARK 3 L TENSOR REMARK 3 L11: 1.6971 L22: 4.1170 REMARK 3 L33: 2.9561 L12: 1.4727 REMARK 3 L13: 0.7502 L23: 1.9377 REMARK 3 S TENSOR REMARK 3 S11: -0.0340 S12: 0.0672 S13: -0.0838 REMARK 3 S21: -0.0545 S22: -0.1406 S23: 0.1295 REMARK 3 S31: 0.0744 S32: -0.0622 S33: 0.1575 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5AGX COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 04-FEB-15. REMARK 100 THE DEPOSITION ID IS D_1290062951. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 19-SEP-14 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : AUSTRALIAN SYNCHROTRON REMARK 200 BEAMLINE : MX2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9537 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : XDS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 20251 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.240 REMARK 200 RESOLUTION RANGE LOW (A) : 40.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 14.20 REMARK 200 R MERGE (I) : 0.07000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 29.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.24 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.32 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.2 REMARK 200 DATA REDUNDANCY IN SHELL : 14.00 REMARK 200 R MERGE FOR SHELL (I) : 0.78000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.890 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: UNPUBLISHED BCL-2 BECLIN BH3 COMPLEX REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47.40 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.34 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PH 7.0 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 43 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+3/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+1/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+3/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+1/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 54.36950 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 43.02700 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 43.02700 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 81.55425 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 43.02700 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 43.02700 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 27.18475 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 43.02700 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 43.02700 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 81.55425 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 43.02700 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 43.02700 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 27.18475 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 54.36950 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2280 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 8110 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -15.4 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2120 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 8310 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -13.9 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 ALA A 2 REMARK 465 HIS A 3 REMARK 465 ALA A 4 REMARK 465 GLY A 5 REMARK 465 ARG A 6 REMARK 465 THR A 7 REMARK 465 GLY A 33 REMARK 465 ASP A 34 REMARK 465 ASP A 76 REMARK 465 VAL A 77 REMARK 465 GLU A 78 REMARK 465 GLU A 79 REMARK 465 ASN A 80 REMARK 465 ARG A 81 REMARK 465 THR A 82 REMARK 465 GLU A 83 REMARK 465 ALA A 84 REMARK 465 PRO A 85 REMARK 465 GLU A 86 REMARK 465 GLY A 87 REMARK 465 THR A 88 REMARK 465 GLU A 89 REMARK 465 SER A 205 REMARK 465 MET A 206 REMARK 465 ARG A 207 REMARK 465 MET B 1 REMARK 465 ALA B 2 REMARK 465 HIS B 3 REMARK 465 ALA B 4 REMARK 465 GLY B 5 REMARK 465 ARG B 6 REMARK 465 THR B 7 REMARK 465 GLY B 33 REMARK 465 ASP B 34 REMARK 465 ASP B 76 REMARK 465 VAL B 77 REMARK 465 GLU B 78 REMARK 465 GLU B 79 REMARK 465 ASN B 80 REMARK 465 ARG B 81 REMARK 465 THR B 82 REMARK 465 GLU B 83 REMARK 465 ALA B 84 REMARK 465 PRO B 85 REMARK 465 GLU B 86 REMARK 465 GLY B 87 REMARK 465 THR B 88 REMARK 465 SER B 205 REMARK 465 MET B 206 REMARK 465 ARG B 207 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 TYR A 9 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 GLU A 91 CG CD OE1 OE2 REMARK 470 ARG A 109 CG CD NE CZ NH1 NH2 REMARK 470 ARG A 110 CG CD NE CZ NH1 NH2 REMARK 470 ALA A 113 CB REMARK 470 GLN A 118 CG CD OE1 NE2 REMARK 470 HIS A 120 CG ND1 CD2 CE1 NE2 REMARK 470 ARG A 164 NE CZ NH1 NH2 REMARK 470 TYR B 9 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 GLU B 89 CG CD OE1 OE2 REMARK 470 GLU B 91 CG CD OE1 OE2 REMARK 470 ARG B 110 NE CZ NH1 NH2 REMARK 470 ALA B 113 CB REMARK 470 GLN B 118 CG CD OE1 NE2 REMARK 470 ARG B 164 CD NE CZ NH1 NH2 REMARK 470 ARG C 20 CG CD NE CZ NH1 NH2 REMARK 470 ARG C 21 CG CD NE CZ NH1 NH2 REMARK 470 ARG D 21 CG CD NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OH TYR B 18 OE2 GLU B 152 2.08 REMARK 500 OG SER B 105 OE1 GLU B 152 2.12 REMARK 500 OD1 ASP A 103 NH1 ARG A 106 2.14 REMARK 500 OH TYR A 18 OE2 GLU A 152 2.18 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 XCP C 2 CA - C - N ANGL. DEV. = -14.1 DEGREES REMARK 500 XCP D 2 CA - C - N ANGL. DEV. = -15.9 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 TYR A 9 -102.10 85.22 REMARK 500 TYR B 9 -150.82 -170.45 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 ILE C 1 XCP C 2 138.02 REMARK 500 ASN C 15 XCP C 16 139.36 REMARK 500 ILE D 1 XCP D 2 139.66 REMARK 500 ASN D 15 XCP D 16 139.88 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: MAIN CHAIN PLANARITY REMARK 500 REMARK 500 THE FOLLOWING RESIDUES HAVE A PSEUDO PLANARITY REMARK 500 TORSION ANGLE, C(I) - CA(I) - N(I+1) - O(I), GREATER REMARK 500 10.0 DEGREES. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 500 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 500 I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI ANGLE REMARK 500 XCP C 2 16.72 REMARK 500 XCP C 16 18.06 REMARK 500 XCP D 2 16.78 REMARK 500 XCP D 16 17.17 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 5AGW RELATED DB: PDB REMARK 900 BCL-2 ALPHA BETA-1 COMPLEX REMARK 999 REMARK 999 SEQUENCE REMARK 999 BCL-2 WITH THE UNSTRUCTURED LOOP BETWEEN RESIDUES 35-91 REMARK 999 REPLACED WITH RESIDUES 35-50 OF BCL-XL DBREF 5AGX A 1 34 UNP P10415 BCL2_HUMAN 1 34 DBREF 5AGX A 76 91 UNP Q07817 B2CL1_HUMAN 29 44 DBREF 5AGX A 92 207 UNP P10415 BCL2_HUMAN 92 207 DBREF 5AGX B 1 34 UNP P10415 BCL2_HUMAN 1 34 DBREF 5AGX B 76 91 UNP Q07817 B2CL1_HUMAN 29 44 DBREF 5AGX B 92 207 UNP P10415 BCL2_HUMAN 92 207 DBREF 5AGX C 1 21 UNP O43521 B2L11_HUMAN 146 166 DBREF 5AGX D 1 21 UNP O43521 B2L11_HUMAN 146 166 SEQADV 5AGX ACE C -1 UNP O43521 EXPRESSION TAG SEQADV 5AGX ACE D -1 UNP O43521 EXPRESSION TAG SEQADV 5AGX XCP C 2 UNP O43521 TRP 147 ENGINEERED MUTATION SEQADV 5AGX AJE C 6 UNP O43521 GLU 151 ENGINEERED MUTATION SEQADV 5AGX MH8 C 9 UNP O43521 ARG 154 ENGINEERED MUTATION SEQADV 5AGX MH8 C 13 UNP O43521 GLU 158 ENGINEERED MUTATION SEQADV 5AGX XCP C 16 UNP O43521 ALA 161 ENGINEERED MUTATION SEQADV 5AGX XCP D 2 UNP O43521 TRP 147 ENGINEERED MUTATION SEQADV 5AGX AJE D 6 UNP O43521 GLU 151 ENGINEERED MUTATION SEQADV 5AGX MH8 D 9 UNP O43521 ARG 154 ENGINEERED MUTATION SEQADV 5AGX MH8 D 13 UNP O43521 GLU 158 ENGINEERED MUTATION SEQADV 5AGX XCP D 16 UNP O43521 ALA 161 ENGINEERED MUTATION SEQRES 1 A 166 MET ALA HIS ALA GLY ARG THR GLY TYR ASP ASN ARG GLU SEQRES 2 A 166 ILE VAL MET LYS TYR ILE HIS TYR LYS LEU SER GLN ARG SEQRES 3 A 166 GLY TYR GLU TRP ASP ALA GLY ASP ASP VAL GLU GLU ASN SEQRES 4 A 166 ARG THR GLU ALA PRO GLU GLY THR GLU SER GLU VAL VAL SEQRES 5 A 166 HIS LEU THR LEU ARG GLN ALA GLY ASP ASP PHE SER ARG SEQRES 6 A 166 ARG TYR ARG ARG ASP PHE ALA GLU MET SER SER GLN LEU SEQRES 7 A 166 HIS LEU THR PRO PHE THR ALA ARG GLY ARG PHE ALA THR SEQRES 8 A 166 VAL VAL GLU GLU LEU PHE ARG ASP GLY VAL ASN TRP GLY SEQRES 9 A 166 ARG ILE VAL ALA PHE PHE GLU PHE GLY GLY VAL MET CYS SEQRES 10 A 166 VAL GLU SER VAL ASN ARG GLU MET SER PRO LEU VAL ASP SEQRES 11 A 166 ASN ILE ALA LEU TRP MET THR GLU TYR LEU ASN ARG HIS SEQRES 12 A 166 LEU HIS THR TRP ILE GLN ASP ASN GLY GLY TRP ASP ALA SEQRES 13 A 166 PHE VAL GLU LEU TYR GLY PRO SER MET ARG SEQRES 1 B 166 MET ALA HIS ALA GLY ARG THR GLY TYR ASP ASN ARG GLU SEQRES 2 B 166 ILE VAL MET LYS TYR ILE HIS TYR LYS LEU SER GLN ARG SEQRES 3 B 166 GLY TYR GLU TRP ASP ALA GLY ASP ASP VAL GLU GLU ASN SEQRES 4 B 166 ARG THR GLU ALA PRO GLU GLY THR GLU SER GLU VAL VAL SEQRES 5 B 166 HIS LEU THR LEU ARG GLN ALA GLY ASP ASP PHE SER ARG SEQRES 6 B 166 ARG TYR ARG ARG ASP PHE ALA GLU MET SER SER GLN LEU SEQRES 7 B 166 HIS LEU THR PRO PHE THR ALA ARG GLY ARG PHE ALA THR SEQRES 8 B 166 VAL VAL GLU GLU LEU PHE ARG ASP GLY VAL ASN TRP GLY SEQRES 9 B 166 ARG ILE VAL ALA PHE PHE GLU PHE GLY GLY VAL MET CYS SEQRES 10 B 166 VAL GLU SER VAL ASN ARG GLU MET SER PRO LEU VAL ASP SEQRES 11 B 166 ASN ILE ALA ILE TRP MET THR GLU TYR LEU ASN ARG HIS SEQRES 12 B 166 LEU HIS THR TRP ILE GLN ASP ASN GLY GLY TRP ASP ALA SEQRES 13 B 166 PHE VAL GLU LEU TYR GLY PRO SER MET ARG SEQRES 1 C 22 ACE ILE XCP ILE ALA GLN AJE LEU ARG MH8 ILE GLY ASP SEQRES 2 C 22 MH8 PHE ASN XCP TYR TYR ALA ARG ARG SEQRES 1 D 22 ACE ILE XCP ILE ALA GLN AJE LEU ARG MH8 ILE GLY ASP SEQRES 2 D 22 MH8 PHE ASN XCP TYR TYR ALA ARG ARG HET ACE C -1 3 HET XCP C 2 8 HET AJE C 6 15 HET MH8 C 9 10 HET MH8 C 13 10 HET XCP C 16 8 HET ACE D -1 3 HET XCP D 2 8 HET AJE D 6 15 HET MH8 D 9 10 HET MH8 D 13 10 HET XCP D 16 8 HETNAM ACE ACETYL GROUP HETNAM XCP (1S,2S)-2-AMINOCYCLOPENTANECARBOXYLIC ACID HETNAM AJE (3S,4R)-4-AMINO-1-(3-CARBOXYPROPANOYL)PYRROLIDINE-3- HETNAM 2 AJE CARBOXYLIC ACID HETNAM MH8 (2S)-2-AMINO-2-METHYLHEPT-6-ENOIC ACID FORMUL 3 ACE 2(C2 H4 O) FORMUL 3 XCP 4(C6 H11 N O2) FORMUL 3 AJE 2(C9 H14 N2 O5) FORMUL 3 MH8 4(C8 H15 N O2) FORMUL 5 HOH *44(H2 O) HELIX 1 1 ASP A 10 ARG A 26 1 17 HELIX 2 2 SER A 90 TYR A 108 1 19 HELIX 3 3 ARG A 109 ALA A 113 5 5 HELIX 4 4 GLU A 114 HIS A 120 1 7 HELIX 5 5 THR A 125 PHE A 138 1 14 HELIX 6 6 ASN A 143 ARG A 164 1 22 HELIX 7 7 PRO A 168 LEU A 185 1 18 HELIX 8 8 LEU A 185 ASN A 192 1 8 HELIX 9 9 GLY A 193 GLY A 203 1 11 HELIX 10 10 ASP B 10 ARG B 26 1 17 HELIX 11 11 SER B 90 TYR B 108 1 19 HELIX 12 12 ARG B 109 ALA B 113 5 5 HELIX 13 13 GLU B 114 HIS B 120 1 7 HELIX 14 14 THR B 125 PHE B 138 1 14 HELIX 15 15 ASN B 143 ARG B 164 1 22 HELIX 16 16 SER B 167 LEU B 185 1 19 HELIX 17 17 LEU B 185 ASN B 192 1 8 HELIX 18 18 GLY B 193 GLY B 203 1 11 LINK C ACE C -1 N ILE C 1 1555 1555 1.32 LINK C ILE C 1 N XCP C 2 1555 1555 1.33 LINK C XCP C 2 N ILE C 3 1555 1555 1.33 LINK C GLN C 5 N AJE C 6 1555 1555 1.33 LINK C AJE C 6 N LEU C 7 1555 1555 1.33 LINK C ARG C 8 N MH8 C 9 1555 1555 1.33 LINK C MH8 C 9 N ILE C 10 1555 1555 1.32 LINK C ASP C 12 N MH8 C 13 1555 1555 1.33 LINK C MH8 C 13 N PHE C 14 1555 1555 1.33 LINK C ASN C 15 N XCP C 16 1555 1555 1.34 LINK C XCP C 16 N TYR C 17 1555 1555 1.33 LINK C ACE D -1 N ILE D 1 1555 1555 1.33 LINK C ILE D 1 N XCP D 2 1555 1555 1.33 LINK C XCP D 2 N ILE D 3 1555 1555 1.33 LINK C GLN D 5 N AJE D 6 1555 1555 1.33 LINK C AJE D 6 N LEU D 7 1555 1555 1.33 LINK C ARG D 8 N MH8 D 9 1555 1555 1.34 LINK C MH8 D 9 N ILE D 10 1555 1555 1.33 LINK C ASP D 12 N MH8 D 13 1555 1555 1.33 LINK C MH8 D 13 N PHE D 14 1555 1555 1.33 LINK C ASN D 15 N XCP D 16 1555 1555 1.34 LINK C XCP D 16 N TYR D 17 1555 1555 1.33 CRYST1 86.054 86.054 108.739 90.00 90.00 90.00 P 43 21 2 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011621 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011621 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009196 0.00000